Hematology & Oncology Market Research Reports & Industry Analysis
Hematology & Oncology Industry Research & Market Reports
-
2024-2029 Singapore Diagnostics Market for 500 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors
... Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2024 supplier shares, strategies, as well as 2024-2029 volume and ... Read More
-
2024-2029 Taiwan Diagnostics Market for 500 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors
... Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2024 supplier shares, strategies, as well as 2024-2029 volume and ... Read More
-
IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development) Technology (Immunoassay, Molecular Diagnostics, Biochemistry) Application (Oncology, Diabetes) – Global Forecast to 2031
... Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development) Technology (Immunoassay, Molecular Diagnostics, Biochemistry) Application (Oncology, Diabetes) – Global Forecast to 2031 The global IVD assay development market is projected to reach $8.39 billion ... Read More
-
2024-2029 Germany Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the German market; reviews current and emerging assays; analyzes potential applications of new ... Read More
-
2024-2029 France Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new ... Read More
-
2024-2029 Hematology and Flow Cytometry: US, Europe, Japan - A Market Facing Regulatory and Competitive Challenges - Supplier Shares and Segment Forecasts by Test - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report explores business and technological ... Read More
-
2024-2029 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in the European market; reviews current and emerging ... Read More
-
2024-2029 Global Cancer Diagnostics Market Segmentation Analysis: US, Europe, Japan - Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Growth Opportunities This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the ... Read More
-
2024-2029 Immunodiagnostics Market: US, Europe, Japan - Spot Fast-Growing Market Segments - Supplier Shares and Segment Forecasts for over 100 Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, and Drugs of Abuse Tests
... LeadingMarketResearch's new seven-country report is a strategic analysis of major business opportunities emerging in the global clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S., five ... Read More
-
2024 Global Cancer Diagnostics Market Players - Market Shares by Country, Strategic Assessments of Major Suppliers and Emerging Market Entrants
... emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, ... Read More
-
2024-2029 Papillomavirus Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Papillomavirus tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024 Physician Office Testing Market: 2023 Supplier Shares and 2023-2029 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic reagent and instrument suppliers develop more effective business, R&D and marketing ... Read More
-
Blood Cell Analyzer
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Semi-automated Biochemistry Analyzers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$687.6 Million ... Read More
-
Hematology Testing Products
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Hematology Diagnostics
... at a CAGR of 5.8% over the analysis period 2023-2030. Hematology Diagnostics Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end ... Read More
-
Cervical Dysplasia Diagnostics
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by ... Read More
-
Next Generation Cancer Diagnostics
... reach US$64.6 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. qPCR & Multiplexing Technology, one of the segments analyzed in the report, is expected to record a 22.4% CAGR ... Read More
-
Cancer Diagnostics Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Cancer Diagnostics Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Cancer Diagnostics Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Global Oncology Information Systems Market 2024-2028
... period. The report on the oncology information systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Femtech Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... report on global femtech market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global femtech market by segmenting ... Read More
-
Artificial Intelligence (AI) in Oncology Market - Forecasts from 2024 to 2029
... in 2029 from US$1.963 billion in 2024. The oncology discipline has seen tremendous breakthroughs with the help of artificial intelligence (AI). Multiple advantages of AI are driving its increased adoption in cancer studies, thereby propelling ... Read More
Research Assistance
